Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines

Molecular and Cellular Biochemistry

Volumn 383, Issue 1-2, 2013, Pages 95-102

  Piotrowska, Hanna ^a   Kucinska, Malgorzata ^a   Murias, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CYP1A1; CYP1B1; Human cancer cell line; Mitochondrial superoxide dismutase

Indexed keywords

3,3',4,4',5,5' HEXAHYDROXYSTILBENE; ANTIOXIDANT; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DRUG METABOLIZING ENZYME; MANGANESE SUPEROXIDE DISMUTASE; RESVERATROL; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG RESPONSE; HELA CELL; HUMAN; HUMAN CELL; IC 50; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN EXPRESSION;

ARYL HYDROCARBON HYDROXYLASES; CELL DEATH; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; PYROGALLOL; STILBENES; SUPEROXIDE DISMUTASE;

EID: 84885433999     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1758-8     Document Type: Article

References (55)

1. Yu LJ, Matias J, Scudiero DA, Hite KM, Monks A, Sausville EA, Waxman DJ (2001) P450 enzyme expression patterns in the NCI human tumor cell line panel. Drug Metab Dispos 29:304-312
2. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6:1483-1491
3. Sokilde R, Kaczkowski B, Podolska A, Cirera S, Gorodkin J, Moller S, Litman T (2011) Global microRNA analysis of the NCI-60 cancer cell panel. Mol Cancer Ther 10:375-384
4. Holbeck S, Chang J, Best AM, Bookout AL, Mangelsdorf DJ, Martinez ED (2010) Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol Endocrinol 24:1287-1296
5. Berglind H, Pawitan Y, Kato S, Ishioka C, Soussi T (2008) Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther 7:699-708
6. Guengerich F, Chun YJ, Kim D, Gillam EM, Shimada T (2003) Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat Res 523-524:173-182
7. Holley AK, Dhar SK, Xu Y, St Clair DK (2012) Manganese superoxide dismutase: beyond life and death. Amino Acids 42:139-158
8. McFadyen MC, Murray GI (2005) Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncol 1:259-263
9. Nandekar PP, Sangamwar AT (2012) Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings. Expert Opin Drug Discov 7:771-789
10. Androutsopoulos VP, Tsatsakis AM, Spandidos DA (2009) Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187
11. Stejskalova L, Pavek P (2011) The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 12:715-730
12. Buettner GR (2011) Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem 11:341-346
13. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St CD, Batinic-Haberle I (2012) Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 1822:794-814
14. Izutani R, Kato M, Asano S, Imano M, Ohyanagi H (2002) Expression of manganese superoxide disumutase influences chemosensitivity in esophageal and gastric cancers. Cancer Detect Prev 26:213-221
15. Malafa M, Margenthaler J, Webb B, Neitzel L, Christophersen M (2000) MnSOD expression is increased in metastatic gastric cancer. J Surg Res 88:130-134
16. Toh Y, Kuninaka S, Oshiro T, Ikeda Y, Nakashima H, Baba H, Kohnoe S, Okamura T, Mori M, Sugimachi K (2000) Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol 17:107-112
17. Venkataraman S, Wagner BA, Jiang X, Wang HP, Schafer FQ, Ritchie JM, Patrick BC, Oberley LW, Buettner GR (2004) Overexpression of manganese superoxide dismutase promotes the survival of prostate cancer cells exposed to hyperthermia. Free Radic Res 38:1119-1132
18. Chung-man HJ, Zheng S, Comhair SA, Farver C, Erzurum SC (2001) Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 61:8578-8585
19. Kiningham KK, St Clair DK (1997) Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res 57:5265-5271
20. Zhao Y, Kiningham KK, Lin SM, St Clair DK (2001) Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFkappaB pathways. Antioxid Redox Signal 3:375-386
21. Oberley LW (2005) Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 59:143-148
22. Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A, Belarmino J, Van De Water L, Mian BM, Melendez JA (2007) Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 67:10260-10267
23. Behrend L, Mohr A, Dick T, Zwacka RM (2005) Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells. Mol Cell Biol 25:7758-7769
24. Dhar SK, Tangpong J, Chaiswing L, Oberley TD, St Clair DK (2011) Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res 71:6684-6695
25. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, Hofseth LJ, Moake M, Nagashima M, Forrester KS, Harris CC (2004) p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64:2350-2356
26. Li Z, Shi K, Guan L, Cao T, Jiang Q, Yang Y, Xu C (2010) ROS leads to MnSOD upregulation through ERK2 translocation and p53 activation in selenite-induced apoptosis of NB4 cells. FEBS Lett 584:2291-2297
27. Pani G, Koch OR, Galeotti T (2009) The p53-p66shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. Int J Biochem Cell Biol 41:1002-1005
28. Pani G, Galeotti T (2011) Role of MnSOD and p66shc in mitochondrial response to p53. Antioxid Redox Signal 15:1715-1727
29. Robbins D, Zhao Y (2012) Oxidative Stress Induced by MnSOD-p53 Interaction: pro- or Anti-Tumorigenic? J Signal Transduct 2012:101465
30. You S, Kong BW, Jeon SY, Foster DN, Kim H (2004) Deregulation of catalase, not MnSOD, is associated with necrotic death of p53-defective DF-1 cells under antimycin A-induced oxidative stress. Mol Cells 18:220-229
31. Mikstacka R, Rimando AM, Dutkiewicz Z, Stefanski T, Sobiak S (2012) Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1. Bioorg Med Chem 20:5117-5126
32. Mikstacka R, Baer-Dubowska W, Wieczorek M, Sobiak S (2008) Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities. Mol Nutr Food Res 52(Suppl 1):S77-S83
33. Piver B, Fer M, Vitrac X, Merillon JM, Dreano Y, Berthou F, Lucas D (2004) Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68:773-782
34. Mikstacka R, Przybylska D, Rimando AM, Baer-Dubowska W (2007) Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 51:517-524
35. So KS, Oh JE, Han JH, Jung HK, Lee YS, Kim SH, Chun YJ, Kim MY (2008) Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt. Arch Pharm Res 31:438-444
36. Chun YJ, Oh YK, Kim BJ, Kim D, Kim SS, Choi HK, Kim MY (2009) Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene. Toxicol Lett 189:84-89
37. Chun YJ, Lee SK, Kim MY (2005) Modulation of human cytochrome P450 1B1 expression by 2,4,3′,5′-tetramethoxystilbene. Drug Metab Dispos 33:1771-1776
38. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, Jager W (2004) Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12:5571-5578
39. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
40. Seibert H, Morchel S, Gulden M (2002) Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration. Toxicol In Vitro 16:289-297
41. Doherty MM, Michael M (2003) Tumoral drug metabolism: perspectives and therapeutic implications. Curr Drug Metab 4:131-149
42. Michael M, Doherty MM (2005) Tumoral drug metabolism: overview and its implications for cancer therapy. J Clin Oncol 23:205-229
43. Svoboda M, Wlcek K, Taferner B, Hering S, Stieger B, Tong D, Zeillinger R, Thalhammer T, Jager W (2011) Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Biomed Pharmacother 65:417-426
44. Miksits M, Wlcek K, Svoboda M, Thalhammer T, Ellinger I, Stefanzl G, Falany CN, Szekeres T, Jaeger W (2010) Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism. Cancer Lett 289:237-245
45. Androutsopoulos V, Arroo RR, Hall JF, Surichan S, Potter GA (2008) Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Breast Cancer Res 10:R39
46. Piotrowska H, Myszkowski K, Ziolkowska A, Kulcenty K, Wierzchowski M, Kaczmarek M, Murias M, Kwiatkowska-Borowczyk E, Jodynis-Liebert J (2012) Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells. Toxicol Appl Pharmacol 263:53-60
47. Bendaly J, Metry KJ, Doll MA, Jiang G, States JC, Smith NB, Neale JR, Holloman JL, Pierce WM, Hein DW (2009) Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts. Xenobiotica 39:399-406
48. Martinez VG, O'Connor R, Liang Y, Clynes M (2008) CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance. Br J Cancer 98:564-570
49. Liu Y, Bodmer WF (2006) Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA 103:976-981
50. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559
51. Debernardis D, Sire EG, De FP, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M (1997) p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 57:870-874
52. Wasielewski M, Elstrodt F, Klijn JG, Berns EM, Schutte M (2006) Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res Treat 99:97-101
53. Gartel AL, Feliciano C, Tyner AL (2003) A new method for determining the status of p53 in tumor cell lines of different origin. Oncol Res 13:405-408
54. Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, Kimura N, Matsuo M, Mizusawa H, Tanaka N, Koyama H, Namba M, Kanamaru R, Kuroki T (1997) Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 19:243-253
55. Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527